[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
November 19, 2008

Chelation Therapy Trials Halted

JAMA. 2008;300(19):2236. doi:10.1001/jama.2008.607

The federal government and investigators have called off or suspended enrollment for 2 clinical trials testing chelation therapy as a treatment for autism or coronary artery disease. Critics charged that the studies had little scientific merit and exposed participants to unacceptable safety risks.

The US Food and Drug Administration has approved chelating agents, which bind and remove heavy metals from the body, for treating acute toxicity of heavy metals. But, according to the National Center for Complimentary and Alternative Medicine (NCCAM), off-label uses of chelating agents contribute to an estimated 800 000 physician visits annually.

First Page Preview View Large
First page PDF preview
First page PDF preview
×